Literature DB >> 25782893

Extensive dissemination of extended spectrum β-lactamase-producing Enterobacteriaceae in a Dutch nursing home.

Ina Willemsen1, Jolande Nelson2, Yvonne Hendriks1, Ans Mulders3, Sandrien Verhoeff3, Paul Mulder4, Robert Roosendaal5, Kim van der Zwaluw6, Carlo Verhulst1, Marjolein Kluytmans-van den Bergh7, Jan Kluytmans1.   

Abstract

OBJECTIVE: Risk factors for rectal carriage of ESBL-E and transmission were investigated in an outbreak of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E).
DESIGN: Rectal carriage of ESBL-E was determined in a cross-sectional survey by culture of perianal swabs or fecal samples. Both phenotypical and genotypical methods were used to detect the production of ESBL. Nosocomial transmission was defined as the presence of genotypically related strains in ≥2 residents within the NH. Patient characteristics and variables in infection control practices were registered to investigate risk factors for transmission.
SETTING: A nursing home (NH) in the southern Netherlands. PARTICIPANTS: Of 189 residents, 160 residents (84.7%) were screened for ESBL-E carriage. Of these 160 residents, 33 (20.6%) were ESBL-E positive. ESBL carriage rates varied substantially between wards (range, 0-47%). Four different ESBL-E clusters were observed. A bla CTX-M1-15 positive E. coli ST131 constituted the largest cluster (n=21) and was found in multiple wards (n=7).
RESULTS: Our investigation revealed extensive clonal dissemination of bla CTX-M1-15-positive E. coli ST131 in a nursing home. Unexplained differences in ESBL prevalence were detected among the wards.
CONCLUSIONS: As NHs constitute potential sources of multidrug-resistant bacteria, it is important to gain a better understanding of the risks factors and routes of transmission of ESBL-E.

Entities:  

Mesh:

Year:  2015        PMID: 25782893     DOI: 10.1017/ice.2014.76

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  12 in total

1.  Duration of rectal colonization with extended-spectrum beta-lactamase-producing Escherichia coli: results of an open, dynamic cohort study in Dutch nursing home residents (2013-2019).

Authors:  Veronica Weterings; Wouter van den Bijllaardt; Martin Bootsma; Yvonne Hendriks; Linda Kilsdonk; Ans Mulders; Jan Kluytmans
Journal:  Antimicrob Resist Infect Control       Date:  2022-07-15       Impact factor: 6.454

2.  Different Escherichia coli B2-ST131 clades (B and C) producing extended-spectrum β-lactamases (ESBL) colonizing residents of Portuguese nursing homes.

Authors:  C Rodrigues; E Machado; S Fernandes; L Peixe; Â Novais
Journal:  Epidemiol Infect       Date:  2017-10-17       Impact factor: 4.434

3.  High Prevalence of Intra-Familial Co-colonization by Extended-Spectrum Cephalosporin Resistant Enterobacteriaceae in Preschool Children and Their Parents in Dutch Households.

Authors:  Apostolos Liakopoulos; Gerrita van den Bunt; Yvon Geurts; Martin C J Bootsma; Mark Toleman; Daniela Ceccarelli; Wilfrid van Pelt; Dik J Mevius
Journal:  Front Microbiol       Date:  2018-02-21       Impact factor: 5.640

4.  Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.

Authors:  Yuko Komatsu; Kei Kasahara; Takashi Inoue; Sang-Tae Lee; Tetsuro Muratani; Hisakazu Yano; Tadaaki Kirita; Keiichi Mikasa
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240

5.  Evaluation of an in vitro model with a novel statistical approach to measure differences in bacterial survival of extended-spectrum β-lactamase-producing Escherichia coli on an inanimate surface.

Authors:  Veronica Weterings; Jacobien Veenemans; Amanda Kleefman; Marjolein Kluytmans-van den Bergh; Paul Mulder; Carlo Verhulst; Ina Willemsen; Jan Kluytmans
Journal:  Antimicrob Resist Infect Control       Date:  2019-06-18       Impact factor: 4.887

6.  High prevalence of multidrug resistant Enterobacteriaceae among residents of long term care facilities in Amsterdam, the Netherlands.

Authors:  Eline van Dulm; Aletta T R Tholen; Annika Pettersson; Martijn S van Rooijen; Ina Willemsen; Peter Molenaar; Marjolein Damen; Paul Gruteke; Paul Oostvogel; Ed J Kuijper; Cees M P M Hertogh; Christina M J E Vandenbroucke-Grauls; Maarten Scholing
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

Review 7.  Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field.

Authors:  Jan T Poolman; Michael Wacker
Journal:  J Infect Dis       Date:  2015-09-02       Impact factor: 5.226

8.  About the usefulness of contact precautions for carriers of extended-spectrum beta-lactamase-producing Escherichia coli.

Authors:  Jean-Ralph Zahar; Laurent Poirel; Claire Dupont; Nicolas Fortineau; Xavier Nassif; Patrice Nordmann
Journal:  BMC Infect Dis       Date:  2015-11-12       Impact factor: 3.090

9.  The infection risk scan (IRIS): standardization and transparency in infection control and antimicrobial use.

Authors:  Ina Willemsen; Jan Kluytmans
Journal:  Antimicrob Resist Infect Control       Date:  2018-03-09       Impact factor: 4.887

10.  ESBL colonization and acquisition in a hospital population: The molecular epidemiology and transmission of resistance genes.

Authors:  Stefan Hagel; Oliwia Makarewicz; Anita Hartung; Daniel Weiß; Claudia Stein; Christian Brandt; Ulrike Schumacher; Ralf Ehricht; Vladimir Patchev; Mathias W Pletz
Journal:  PLoS One       Date:  2019-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.